214 related articles for article (PubMed ID: 480183)
21. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition.
Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF
Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a potential tigecycline-warfarin drug interaction.
Zimmerman JJ; Raible DG; Harper DM; Matschke K; Speth JL
Pharmacotherapy; 2008 Jul; 28(7):895-905. PubMed ID: 18576904
[TBL] [Abstract][Full Text] [Related]
23. Influence of renal dysfunction on warfarin plasma protein binding.
Bachmann K; Shapiro R; Mackiewicz J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):468-72. PubMed ID: 977790
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
Wolfe BM; Kane JP; Havel RJ; Brewster HP
J Clin Invest; 1973 Sep; 52(9):2146-59. PubMed ID: 4353773
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
Routledge PA; Chapman PH; Davies DM; Rawlins MD
Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
[TBL] [Abstract][Full Text] [Related]
26. Effect of digoxin on plasma clearance and anticoagulant effect of warfarin in rats.
Ogiso T; Iwaki M; Konishi Y
J Pharmacobiodyn; 1984 Mar; 7(3):186-94. PubMed ID: 6747809
[TBL] [Abstract][Full Text] [Related]
27. Salivary excretion of warfarin in rabbits: relationship between pharmacological effect and salivary pharmacokinetics of warfarin in rabbits.
Sakai K; Nishiura A; Fujihara Y; Kutsuna T; Nishino T
J Pharmacobiodyn; 1983 Dec; 6(12):991-9. PubMed ID: 6674482
[TBL] [Abstract][Full Text] [Related]
28. Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats.
Ogiso T; Iwaki M; Konishi Y
J Pharmacobiodyn; 1982 Oct; 5(10):829-40. PubMed ID: 7161710
[TBL] [Abstract][Full Text] [Related]
29. Interaction between warfarin and propafenone in healthy volunteer subjects.
Kates RE; Yee YG; Kirsten EB
Clin Pharmacol Ther; 1987 Sep; 42(3):305-11. PubMed ID: 3621785
[TBL] [Abstract][Full Text] [Related]
30. Temafloxacin does not potentiate the anticoagulant effect of warfarin in healthy subjects.
Millar E; Coles S; Wyld P; Nimmo W
Clin Pharmacokinet; 1992; 22 Suppl 1():102-6. PubMed ID: 1319866
[TBL] [Abstract][Full Text] [Related]
31. Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.
Williams RL; Schary WL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
Clin Pharmacol Ther; 1976 Jul; 20(1):90-7. PubMed ID: 1277729
[TBL] [Abstract][Full Text] [Related]
32. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
[TBL] [Abstract][Full Text] [Related]
33. Stereoselective interaction between the R enantiomer of warfarin and cimetidine.
Choonara IA; Cholerton S; Haynes BP; Breckenridge AM; Park BK
Br J Clin Pharmacol; 1986 Mar; 21(3):271-7. PubMed ID: 2938614
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.
Sellers EM; Koch-Weser J
N Engl J Med; 1970 Oct; 283(16):827-31. PubMed ID: 5458032
[No Abstract] [Full Text] [Related]
35. Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.
Slattery JT; Yacobi A; Levy G
J Pharm Sci; 1977 Jul; 66(7):943-7. PubMed ID: 886455
[TBL] [Abstract][Full Text] [Related]
36. Age as a determinant of sensitivity to warfarin.
Shepherd AM; Hewick DS; Moreland TA; Stevenson IH
Br J Clin Pharmacol; 1977 Jun; 4(3):315-20. PubMed ID: 901699
[TBL] [Abstract][Full Text] [Related]
37. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
Apseloff G; Wilner KD; Gerber N
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
[TBL] [Abstract][Full Text] [Related]
38. Warfarin in the dog: pharmacokinetics as related to clinical response.
Neff-Davis CA; Davis LE; Gillette EL
J Vet Pharmacol Ther; 1981 Jun; 4(2):135-40. PubMed ID: 7349326
[TBL] [Abstract][Full Text] [Related]
39. Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Benedek IH; King SY; Powell RJ; Agra AM; Schary WL; Pieniaszek HJ
J Clin Pharmacol; 1992 Jun; 32(6):558-63. PubMed ID: 1634644
[TBL] [Abstract][Full Text] [Related]
40. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
O'Reilly RA; Trager WF; Rettie AE; Goulart DA
Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
